Sialic acid functions in enterovirus 70 binding and infection

被引:56
作者
Alexander, DA [1 ]
Dimock, K [1 ]
机构
[1] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
关键词
D O I
10.1128/JVI.76.22.11265-11272.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The interaction of viruses with host cell receptors is the initial step in viral infection and is an important determinant of virus host range, tissue tropism, and pathogenesis. The complement regulatory protein decay-accelerating factor (DAF/CD55) is an attachment receptor for enterovirus 70 (EV70), a member of the Picornaviridae, commonly associated with an eye infection in humans known as acute hemorrhagic conjunctivitis. In early work, the EV70 receptor on erythrocytes, responsible for its hemagglutinating activity, was shown to be sensitive to neuraminidase, implying an essential role for sialic acid in virus attachment. Here, we extend these results to show that cell surface sialic acid is required for EV70 binding to nucleated cells susceptible to virus infection and that sialic acid binding is important in productive infection. Through the use of site-directed mutagenesis to eliminate the single N-linked glycosylation site of DAF and of a chimeric receptor protein in which the O-glycosylated domain of DAF was replaced by a region of the HLA-B44 molecule, a role in EV70 binding for the sialic acid residues of DAF was excluded, suggesting the existence of at least one additional, sialylated EV70-binding factor at the cell surface. Treatment of cells with metabolic inhibitors of glycosylation excluded a role for the N-linked oligosaccharides of glycoproteins but suggested that O-linked glycosylation is important for EV70 binding.
引用
收藏
页码:11265 / 11272
页数:8
相关论文
共 52 条
[31]   Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor [J].
Powell, RM ;
Schmitt, V ;
Ward, T ;
Goodfellow, I ;
Evans, DJ ;
Almond, JW .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :1707-1713
[32]   Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): Evidence for a secondary cellular factor in A-particle formation (vol 71, pg 9308, 1997) [J].
Powell, RM ;
Ward, T ;
Evans, DJ ;
Almond, JW .
JOURNAL OF VIROLOGY, 1998, 72 (01) :890-890
[33]   Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70 [J].
Savolainen, C ;
Blomqvist, S ;
Mulders, MN ;
Hovi, T .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :333-340
[34]   Attachment of coxsackievirus B3 variants to various cell lines: Mapping of phenotypic differences to capsid protein VP1 [J].
Schmidtke, M ;
Selinka, HC ;
Heim, A ;
Jahn, B ;
Tonew, M ;
Kandolf, R ;
Stelzner, A ;
Zell, R .
VIROLOGY, 2000, 275 (01) :77-88
[35]   Cellular receptors for viruses: links to tropism and pathogenesis [J].
Schneider-Schaulies, J .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :1413-1429
[36]   A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells [J].
Shafren, DR ;
Williams, DT ;
Barry, RD .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9844-9848
[37]   COXSACKIEVIRUSES B1, B3, AND B5 USE DECAY-ACCELERATING FACTOR AS A RECEPTOR FOR CELL ATTACHMENT [J].
SHAFREN, DR ;
BATES, RC ;
AGREZ, MV ;
HERD, RL ;
BURNS, GF ;
BARRY, RD .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3873-3877
[38]   Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry [J].
Shafren, DR ;
Dorahy, DJ ;
Ingham, RA ;
Burns, GF ;
Barry, RD .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4736-4743
[39]   Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis [J].
Shulman, LM ;
Manor, Y ;
Azar, R ;
Handsher, R ;
Vonsover, A ;
Mendelson, E ;
Rothman, S ;
Hassin, D ;
Halmut, T ;
Abramovitz, B ;
Varsano, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2145-2149
[40]   Echoviruses and Coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF [J].
Spiller, OB ;
Goodfellow, IG ;
Evans, DJ ;
Almond, JW ;
Morgan, BP .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :340-343